Soligenix
SNGX
#10222
Rank
ยฃ11.95 M
Marketcap
ยฃ1.19
Share price
-1.86%
Change (1 day)
-56.70%
Change (1 year)

EPS for Soligenix (SNGX)

EPS in 2025 (TTM): -ยฃ2.43

According to Soligenix's latest financial reports the company's current EPS (TTM) is -ยฃ2.43. In 2024 the company made an earnings per share (EPS) of -ยฃ3.74 an increase over its 2023 EPS that were of -ยฃ9.50.

EPS history for Soligenix from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ2.43-34.9%
2024-ยฃ3.74-60.66%
2023-ยฃ9.50-83.55%
2022-ยฃ57.7313.95%
2021-ยฃ50.66-56.03%
2020-ยฃ115.2333.33%
2019-ยฃ86.42-29.41%
2018-ยฃ122.43-41.38%
2017-ยฃ208.8524.73%
2016-ยฃ167.44-69%
2015-ยฃ540.13-6.25%
2014-ยฃ576.14-50.77%
2013-ยฃ1,17075.68%
2012-ยฃ666.1668.18%
2011-ยฃ396.10-69.86%
2010-ยฃ1,314-8.75%
2009-ยฃ1,44033.33%
2008-ยฃ1,080-57.14%
2007-ยฃ2,521-46.15%
2006-ยฃ4,68144.44%
2005-ยฃ3,241-40.7%
2004-ยฃ5,465-15.62%
2003-ยฃ6,477-25.52%
2002-ยฃ8,697-80.94%
2001-ยฃ45,627160.89%
2000-ยฃ17,489-40.57%
1999-ยฃ29,426-63.84%
1998-ยฃ81,380601.73%
1997-ยฃ11,597101.7%
1996-ยฃ5,750

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Emergent BioSolutions
EBS
ยฃ1.06-143.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ2.78-214.37%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
ยฃ1.29-153.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ7.83-422.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ1.52-37.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-ยฃ0.71-70.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ0.47-119.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel